Found: 7
Select item for more details and to access through your institution.
In‐house molecular diagnosis of diffuse glioma updating the revised WHO classification by a platform of the advanced medical care system, Senshin‐Iryo.
- Published in:
- Neuropathology, 2024, v. 44, n. 5, p. 344, doi. 10.1111/neup.12970
- By:
- Publication type:
- Article
Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic device.
- Published in:
- Molecular Biology Reports, 2021, v. 48, n. 1, p. 395, doi. 10.1007/s11033-020-06061-7
- By:
- Publication type:
- Article
Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
- Published in:
- Journal of Neurosurgery, 2019, v. 130, n. 1, p. 44, doi. 10.3171/2017.8.JNS1788
- By:
- Publication type:
- Article
Pediatric ganglioglioma with an H3 K27M mutation arising from the cervical spinal cord.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
High‐resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
- Published in:
- Neuropathology, 2018, v. 38, n. 1, p. 3, doi. 10.1111/neup.12408
- By:
- Publication type:
- Article
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 1, p. 47, doi. 10.1007/s11060-020-03682-7
- By:
- Publication type:
- Article
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 451, doi. 10.1007/s11060-019-03339-0
- By:
- Publication type:
- Article